Storkus WJ - Search Results

1

Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.

Tüting T, Wilson CC, Martin DM, Kasamon YL, Rowles J, Ma DI, Slingluff CL Jr, Wagner SN, van der Bruggen P, Baar J, Lotze MT, Storkus WJ. Tüting T, et al. Among authors: storkus wj. J Immunol. 1998 Feb 1;160(3):1139-47. J Immunol. 1998. PMID: 9570527

2

Peptide-induced modulation of target cell sensitivity to natural killing.

Storkus WJ, Salter RD, Cresswell P, Dawson JR. Storkus WJ, et al. J Immunol. 1992 Aug 15;149(4):1185-90. J Immunol. 1992. PMID: 1500711

3

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity.

Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, et al. Mayordomo JI, et al. Among authors: storkus wj. Nat Med. 1995 Dec;1(12):1297-302. doi: 10.1038/nm1295-1297. Nat Med. 1995. PMID: 7489412

4

Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution.

Storkus WJ, Zeh HJ 3rd, Salter RD, Lotze MT. Storkus WJ, et al. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):94-103. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7506576

5

Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.

Itoh T, Storkus WJ, Gorelik E, Lotze MT. Itoh T, et al. Among authors: storkus wj. J Immunol. 1994 Aug 1;153(3):1202-15. J Immunol. 1994. PMID: 7517974

6

Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.

Frassanito MA, Mayordomo JI, DeLeo RM, Storkus WJ, Lotze MT, DeLeo AB. Frassanito MA, et al. Among authors: storkus wj. Cancer Res. 1995 Jan 1;55(1):124-8. Cancer Res. 1995. PMID: 7528638

7

Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.

Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT. Zitvogel L, et al. Among authors: storkus wj. J Immunol. 1995 Aug 1;155(3):1393-403. J Immunol. 1995. PMID: 7636204

8

Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes.

Maeurer MJ, Martin DM, Castelli C, Elder E, Leder G, Storkus WJ, Lotze MT. Maeurer MJ, et al. Among authors: storkus wj. Cancer Immunol Immunother. 1995 Aug;41(2):111-21. doi: 10.1007/BF01527407. Cancer Immunol Immunother. 1995. PMID: 7656270 Free PMC article.

9

Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.

Storkus WJ, Zeh HJ 3rd, Maeurer MJ, Salter RD, Lotze MT. Storkus WJ, et al. J Immunol. 1993 Oct 1;151(7):3719-27. J Immunol. 1993. PMID: 7690811

10

Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.

Zitvogel L, Tahara H, Cai Q, Storkus WJ, Muller G, Wolf SF, Gately M, Robbins PD, Lotze MT. Zitvogel L, et al. Among authors: storkus wj. Hum Gene Ther. 1994 Dec;5(12):1493-506. doi: 10.1089/hum.1994.5.12-1493. Hum Gene Ther. 1994. PMID: 7711142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters